<scp><i>MYC</i></scp> translocation is a valuable marker for the development and relapse of extramedullary disease in multiple myelomaYuhang Song, Junling Zhuang, Daobin Zhou et al.|European Journal Of Haematology|2024Cited by 5
Prognostic Implications of Circulating Plasma Cell Percentage in Multiple Myeloma and Primary Plasma Cell Leukemia Defined by New CriteriaXianghong Jin, Junling Zhuang, Xianyong Jiang et al.|Acta Haematologica|2024Cited by 2
[The value of chest computerized tomography in evaluation of bone disease and clinical prognosis of multiple myeloma].Wenjiao Tang, Junling Zhuang, Daobin Zhou et al.|PubMed|2015Cited by 2
The Role of Next-Generation Sequencing in Predicting Early Relapse for Newly Diagnosed Multiple Myeloma Patients Treated with VRD RegimenLili Cheng, Hui Li, Fujing Zhang et al.|Blood|2024Cited by 1
Myc Translocation Is an Adverse Factor Redefining High-Risk Multiple MyelomaXianghong Jin, Junling Zhuang, Hui Li et al.|Blood|2022Cited by 0